Examining the Activities of Pharmacy and Therapeutics Committees: An Exploratory Study

Journal of Pharmaceutical Marketing and Management

Volumn 14, Issue 2, 2001, Pages 1-29

  Nair, Kavita V ^a   Ascione, Frank J ^b   Bagozzi, Richard P ^c   Benton, Dwight F ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c RICE UNIVERSITY   (United States)

Author keywords

decision making; formularies; models of group behavior; P T committees

Indexed keywords

EID: 84888920239     PISSN: 08837597     EISSN: 15408574     Source Type: Journal    
DOI: 10.3109/J058v14n02_01     Document Type: Article

References (43)

1. Summers K, Szeinbach S. Formularies: The role of pharmacy and therapeutics (P&T) committees. Clin Ther. 1993; 15: 433 – 9.
2. Weekes L, Brooks C, Day R. Indicators for drugs and therapeutics committees. Brit J Clin Pharmacol. 1998; 45: 393 – 8.
3. Fijn R, Brouwers JR, Knaap RJ, De Jong-Van Den Berg LT. Drug and therapeu-tics (D&T) committees in Dutch hospitals: A nation-wide survey of structure, activi-ties, and drug selection procedures. Brit J Clin Pharmacol. 1999; 48 (2): 239 – 46.
4. Thurman PA, Harder S, Steiff A. Structure and activities of hospital drug com-mittees in Germany. Eur J Clin Pharmacol. 1997; 52: 429 – 35.
5. Manasse H. Medication use in an imperfect world: Drug mis-adventuring as an issue of public policy. Am J Health-Syst Pharm. 1989; 46: 929 – 44.
6. Vogel D. Patient focused care. Am J Hosp Pharm. 1993; 50: 2321 – 9.
7. Gordon K. Group judgements in the field of lifted weights. J Exp Psychol. 1924; 7: 398 – 400.
8. Shaw MA. A comparison of individuals and small groups in the rational solu-tion of complex problems. Am J Psychol. 1932; 44: 491 – 504.
9. Lewin K. Resolving social conflicts. New York: Harper; 1948.
10. Bales R. Interaction process analysis: A method for the study of small groups. Cambridge, MA: Addison-Wesley; 1950.
11. Festinger L. Informal social communication. Psychol Rev. 1950; 57: 271 – 92.
12. Deutsch M. Distributive justice: A social psychological perspective. New Ha-ven, CT: Yale University Press; 1985.
13. Stasser G, Kerr N, Davis J. Influence processes and consensus models in deci-sion making groups. In: Psychology of group influence. Paulus B, ed. Hillsdale, NJ: Erlbaum; 1989: 279 – 326.
14. McGrath J. Interaction and performance. Englewood Cliffs, NJ: Prentice-Hall; 1984.
15. Kolodny H, Kiggundu M. Towards the development of a sociotechnical sys-tems model in woodland mechanical harvesting. Hum Relations. 1980; 33: 623 – 45.
16. Gladstein D. Groups in context: A model of task group effectiveness. Admin Sci Q. 1984; 29: 499 – 517.
17. Goodman P, Ravlin E, Schminke M. Understanding groups in organizations. In: Research in organizational behavior. Cummings L, Straw B, eds. Greenwich, CT: JAI Press; 1987: 121 – 75.
18. Shea G, Guzzo R. Group effectiveness: What really matters? Sloan Manage Rev. 1987; 28: 25-31.
19. Pearce J, Ravlin E. The design and activation of self regulating work groups. Hum Relations. 1987; 40: 751 – 82.
20. Ancona D, Caldwell D. Beyond task and maintenance: Defining external func-tions in groups. Group Organiz Studies. 1988; 13: 468 – 94.
21. Ancona D, Caldwell D. Bridging the boundary: External activity and perfor-mance in organizational teams. Admin Sci Q. 1992; 37: 634 – 65.
22. Hackman J. The design of work teams. In: Handbook of organizational behav-ior. Lorsch J, ed. Englewood Cliffs, NJ: Prentice Hall; 1987: 315 – 42.
23. Mannebach M, Ascione FJ, Gaither C, Bagozzi RP, Cohen I, Ryan M. Activ-ities, functions, and structure of pharmacy and therapeutic committees in large teach-ing hospitals. Am J Health-Syst Pharm. 1999; 56: 623 – 7.
24. Nair KV, Ascione FJ, Mannebach M, Bagozzi RP. An organizational tool to evaluate the determinants of P&T committee performance. J Am Pharm Assoc. 2000; in press.
25. Barner JC, Thomas J. Participation and influence of individuals and committees that decide on drug availability in HMOs. Am J Health-Syst Pharm. 1998; 55: 56 – 61.
26. Heemink I, Tabit E, Mar Melero M, Waning B. Review of the functioning of P&T committees in Boston area hospitals. Part 2. P&T. 1999; 24(Jun):264, 267 – 270, 275 – 278, 280.
27. Hillman D. The design and administration of mail surveys. Ann Rev Sociol. 1991; 17: 225 – 49.
28. Anderson J, Gerbing D. The effect of sampling error on convergence, improper solutions, and goodness-of-fit indices for maximum likelihood confirmatory factor analysis. Psychometrika. 1984; 49: 155 – 73.
29. Boomsma A. The robustness of LISREL against small sample sizes in factor analysis models. In: Systems under indirect observation: Causality, structure and pre-diction. Joreskog K, Wold J, eds. New York: North Holland; 1982.
30. Bagozzi R, Heatherton T. A general approach to representing multifaceted per-sonality constructs: Application to state self-esteem. Structural Equation Model. 1994; 1: 35 – 67.
31. Bagozzi R, Yi Y. On the evaluation of structural equation models. J Acad Mar-ket Sci. 1988; 16: 74 – 94.
32. Nash D, Catalano M, Wordell C. The formulary decision making process in a U.S. academic medical center. Pharmacoeconomics. 1993; 3: 22 – 35.
33. Pillans P, Conry I, Gie B. Drug cost containment at a large teaching hospital. Pharmacoeconomics. 1992; 1: 377 – 82.
34. Cano S. Formularies in integrated health systems: Fallon Healthcare System. Am J Health-Syst Pharm. 1996; 1: 270 – 4.
35. Rizos A, Levy E, Furnier J, Crowley K. Formularies in integrated health sys-tems: Sharp Healthcare. Am J Health-Syst Pharm. 1996; 53: 274 – 8.
36. Osborne J. Formularies in integrated health systems: Integris Health. Am J Health-Syst Pharm. 1996; 53: 278 – 81.
37. Gannon K. More power to you. Hosp Pharm Rep. 1998; 12(Feb): 18 – 20.
38. Dana WJ, McWhinney B. Managing high cost and biotech drugs: Two institu-tions' perspectives. Hosp Form. 1994; 29: 639 – 45.
39. Arriola E. The changing relationship between health care professionals and the pharmaceutical industry. Hosp Form. 1995; 30: 161 – 9.
40. Reeder C, Dickson M, Sante11 J. ASHP survey of pharmacy practice in acute care settings-1996. Am J Health-Syst Pharm. 1997; 54: 653 – 69.
41. Alderfer C. Boundary relations and organizational diagnosis. In: Humanizing organizational behavior. Meltzer M, ed. Springfield, IL: Charles C. Thomas; 1976: 42 – 175.
42. Guzzo RA, Shea GP. Group performance and intergroup relations in organiza-tions. In: Handbook of industrial and organizational psychology. Vol. 3. 2nd ed. Dunnette MD, Hough LM, eds. Palo Alto, CA: Consulting Psychologists Press; 1992: 269 – 313.
43. Weekes L, Brooks C, Day R. Indicators for drugs and therapeutics committees. Brit J Clin Pharmacol. 1998; 45: 393 – 8.